'Quick Test' Could Determine
HIV Patients' Drug Resistance

A private Belgian genomics company has developed a quick test to predict drug resistance in patients infected with HIV, the virus that causes AIDS.

Virco Group NV (www.vircolab.com ) claims that the test will help doctors better tailor treatment for HIV-infected patients. Reporting their findings at a major AIDS conference in Chicago, Virco researchers explained the test involves comparing genetic information from patients' samples to a computer database of viral information. In this way, a doctor could obtain an averaged...